RPS2 and acute myeloid leukemia: Other groups have reported an upregulation of rRNA processing and ribosomal biogenesis in NPM1 mutated AML via the ribosomal protein S2 (RPS2), suggesting a possible target for therapeutic intervention (Feng et al., 2023).